Email Updates
Go to Basic Search
Results
Total Results: over 10,000 records
Showing results for "analyzed".
-
srdr.ahrq.gov/projects/1565/studies/198067January 01, 2020 - Definition of OSA Sleep technicians manually analyzed … CPAP Baseline N/A N Analyzed 55 49 … P-Value Adjusted For: 12 months N Analyzed … CPAP Baseline N/A N Analyzed 55 49 … P-Value Adjusted For: 12 months N Analyzed
-
psnet.ahrq.gov/issue/strategies-learning-failureSeptember 25, 2024 - interventions such as checklists —and unavoidable failures in complex organizations, which should be reported, analyzed … The author, who has extensively analyzed high-profile failures in many industries, recommends that organizations
-
www.ahrq.gov/news/newsroom/case-studies/cdom1102.htmlOctober 01, 2014 - Kayani, PhD, and Sherri Homan, RN, PhD, Section of Epidemiology for Public Health Practices at DHSS, analyzed … Safety Net Monitoring Initiative' databooks were the beginning of the data we collected, updated, and analyzed
-
srdr.ahrq.gov/projects/1520/studies/192910January 01, 2020 - ERROR 30 days N Analyzed 84 94 P-Value 0.1 Counts … ERROR 1 weeks N Analyzed 84 94 P-Value 0.07 Counts … 5 1 30 days N Analyzed 84 94 P-Value … ERROR 30 days N Analyzed 84 94 P-Value 0.3 Counts … ERROR 24 hours N Analyzed 84 94 P-Value 0.9 Median
-
srdr.ahrq.gov/projects/1312/studies/133185January 01, 2008 - Comments ( 0 ) | Post/View n Analyzed … Participants Time Point Measure Exposure 1 Exposure 2 Control 1 0 hours N Analyzed … 2.6 3 SE 2 hours N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133322January 01, 2014 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 hours N Analyzed … 2.2 2.5 SE 2 hours N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133309January 01, 2014 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 weeks N Analyzed … .56 SE 1 week 90 minutes N/A N Analyzed
-
srdr.ahrq.gov/projects/1520/studies/186807January 01, 2013 - Placebo 2 years N Analyzed 45 47 P-Value >0.05 Counts … Population: All Participants Time Point Measure Pharm: 5-ASA Placebo 2 years N Analyzed … Population: All Participants Time Point Measure Pharm: 5-ASA Placebo 2 years N Analyzed … Placebo 2 years N Analyzed 45 47 P-Value 0.022 Mean … Placebo 2 years N Analyzed 45 47 P-Value >0.05 Mean
-
digital.ahrq.gov/ahrq-funded-projects/past-initiatives/privacy-and-security-project/impact-analysis-privacy-and-security-solutionsJanuary 01, 2023 - Each State team analyzed variations in organization-level business practices, policies, and State laws … In late 2007, RTI analyzed the impact of the HISPC on the participating States and cross-state data exchange
-
srdr.ahrq.gov/projects/1520/studies/186815January 01, 2018 - Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … symptoms Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … symptoms Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed … Participants Time Point Measure Colonoscopy Enter a numeric value or title (required) years N Analyzed
-
Psn-Pdf (pdf file)
psnet.ahrq.gov/node/40365/psn-pdfFebruary 12, 2014 - interventions such as checklists—and unavoidable failures in complex organizations, which should be reported, analyzed … The author, who has extensively analyzed high- profile failures in many industries, recommends that -
srdr.ahrq.gov/projects/1565/studies/189225January 01, 2015 - CPAP 1 years N Analyzed 128 167 … Percentage 9.4 12.0 5 years N Analyzed … CPAP 1 years N Analyzed 128 167 Adj … Adjusted For: Note 5 years N Analyzed … CPAP 1 years N Analyzed 128 167
-
srdr.ahrq.gov/projects/1565/studies/188968January 01, 2012 - No CPAP 2 years N Analyzed 94 94 … Population: All Participants Time Point Measure CPAP No CPAP 2 years N Analyzed … No CPAP 6 months N Analyzed 165 158 … No CPAP 6 months N Analyzed 167 163 … No CPAP 6 months N Analyzed 110 108
-
srdr.ahrq.gov/projects/1520/studies/186160January 01, 2015 - Population: All Participants Time Point Measure IR: Percutaneous drainage 4-6 weeks N Analyzed … Population: All Participants Time Point Measure IR: Percutaneous drainage 4-6 weeks N Analyzed … Population: All Participants Time Point Measure IR: Percutaneous drainage 4-6 weeks N Analyzed … Population: All Participants Time Point Measure IR: Percutaneous drainage 4-6 weeks N Analyzed … Population: All Participants Time Point Measure IR: Percutaneous drainage 48 hours N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133267January 01, 2015 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 hours N Analyzed … .74 1.76 SE 2 hours N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133270January 01, 2011 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Control 1 Exposure 1 0 hours N Analyzed … SE .6 .5 6 hours N Analyzed
-
srdr.ahrq.gov/projects/1312/studies/133339January 01, 2013 - Comments ( 0 ) | Post/View n Analyzed … All Participants Time Point Measure Exposure 1 Control 1 0 hours N Analyzed … .39 .3 SE 24 hours N Analyzed
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsxSeptember 30, 2015 - Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … Urine + for opiates: 63% Self-reported use of opiates: 89% Screened: 65 Eligible: 25 Randomized: 19 Analyzed … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs. … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsxSeptember 30, 2015 - Setting Country Eligibility Criteria Interventions Sample Characteristics Screened Eligible Randomized Analyzed … B Screened: 88 Eligible: 30 Randomized: 30 Analyzed: 27 A vs. … Urine + for opiates: 63% Self-reported use of opiates: 89% Screened: 65 Eligible: 25 Randomized: 19 Analyzed … B Screened: 68 Eligible: 53 Randomized: 46 Analyzed: 40 (20 vs. 20) A vs. … Comparison Groups Population Characteristics Method for Assessing Outcomes and Confounders Enrolled Analyzed
-
srdr.ahrq.gov/projects/1565/studies/188522January 01, 2019 - No CPAP Enter a numeric value or title (required) years N Analyzed 1030 … No CPAP Enter a numeric value or title (required) years N Analyzed 1030 … No CPAP Enter a numeric value or title (required) years N Analyzed 1030 … No CPAP Enter a numeric value or title (required) years N Analyzed 1030
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
Click to show only results for the selected site.
www.ahrq.gov (2846)
psnet.ahrq.gov (2792)
cmext.ahrq.gov (2386)
ce.effectivehealthcare.ahrq.gov (1615)
effectivehealthcare-admin.ahrq.gov (1460)
effectivehealthcare.ahrq.gov (1409)
digital.ahrq.gov (1172)
www.qualitymeasures.ahrq.gov (870)
www.talkingquality.ahrq.gov (614)
www.monahrq.ahrq.gov (580)
www.healthcare411.ahrq.gov (573)
www.innovations.ahrq.gov (572)
www.cahps.ahrq.gov (520)
www.cpsi.ahrq.gov (475)
pcmh.ahrq.gov (454)
pbrn.ahrq.gov (430)
hcup-us.ahrq.gov (429)
cahps.ahrq.gov (423)
monahrq.ahrq.gov (420)
healthcare411.ahrq.gov (419)
www.uspreventiveservicestaskforce.org (401)
meps.ahrq.gov (395)
talkingquality.ahrq.gov (364)
patientregistry.ahrq.gov (361)
ahrqpubs.ahrq.gov (339)
srdr.ahrq.gov (327)
preventiveservices.ahrq.gov (289)
teamstepps.ahrq.gov (273)
cds.ahrq.gov (66)
cdsic.ahrq.gov (50)
www.psoppc.org (44)
qualityindicators.ahrq.gov (25)
pso.ahrq.gov (20)
covid-acts.ahrq.gov (16)
staging-meps.ahrq.gov (14)
srdrplus.ahrq.gov (8)
cahpsdatabase.ahrq.gov (7)
datatools.ahrq.gov (5)
nhqrnet.ahrq.gov (5)
info.ahrq.gov (3)
hcup.ahrq.gov (1)
